pharmaceutical-investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
United States Department of Health and Human Services Publishes New HIV Treatment Guidelines Including Trogarzo
pharmaceutical-investing European Medicines Agency Validates Marketing Authorization Application for Trogarzo
pharmaceutical-investing European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo
pharmaceutical-investing Theratechnologies Announces Financial Results for the Second Quarter of 2018
pharmaceutical-investing Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA (Tesamorelin for Injection) for FDA Approval
